簇集素损害肝脏胰岛素敏感性且脂肪细胞簇集素与心血管代谢风险相关
研究在肥胖与瘦者中验证脂肪细胞簇集素表达升高,并分析其与胰岛素抵抗及心血管代谢风险的关系。脂肪细胞簇集素与胰岛素抵抗、心血管生物标志物及心血管疾病风险独立相关。机制上簇集素通过LRP2受体损害肝细胞胰岛素信号并促进糖异生,在老年LDLR-/-小鼠中与肝脂肪变性和纤维化进展相关。
要点
- 脂肪细胞簇集素与胰岛素抵抗及心血管疾病风险独立相关。
- 簇集素经LRP2受体损害肝细胞胰岛素信号并促进糖异生。
- 老年LDLR-/-小鼠中脂肪细胞簇集素与肝脂肪变性和纤维化进展相关。
核心结论
- 脂肪细胞来源的簇集素是一种新的细胞外基质相关蛋白,通过其在肝脏中的作用连接心血管代谢疾病与肥胖。
研究设计与样本
- 在18名瘦者和54名肥胖者中验证脂肪细胞簇集素表达升高,并分析其与胰岛素抵抗、心血管生物标志物及心血管疾病风险的关系。
- 进一步在人培养细胞和易发肥胖相关并发症的老年LDLR-/-小鼠中进行研究。
主要发现
- 皮下脂肪组织脂肪细胞簇集素与胰岛素抵抗、多种心血管疾病生物标志物及心血管疾病风险相关,且独立于传统危险因素。
- 循环簇集素表现出相似的关联。
- 在人脂肪细胞中,棕榈酸酯增强簇集素分泌;在人肝细胞中,簇集素减弱胰岛素信号和APOA1表达,并刺激肝脏糖异生。
- LRP2(巨蛋白)介导上述效应,LRP2 siRNA可抑制这些效应。
- 在老年LDLR-/-小鼠中,西方饮食喂养后脂肪细胞簇集素表达增加与肝脂肪、脂肪性肝炎和纤维化的进行性增加相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Components of the adipose tissue (AT) extracellular matrix (ECM) are recently discovered contributors to obesity-related cardiometabolic disease. We identified increased adipocyte expression of ECM-related clusterin (apolipoprotein J) in obese versus lean women by microarray. Our objective was to determine 1) whether subcutaneous AT adipocyte (SAd) clusterin and serum clusterin are associated with insulin resistance (IR) and known markers of cardiometabolic risk and 2) how clusterin may contribute to increased risk. RESEARCH DESIGN AND METHODS: We validated increased clusterin expression in adipocytes from a separate group of 18 lean and 54 obese individuals. The relationship of clusterin gene expression and plasma clusterin with IR, cardiovascular biomarkers, and risk of cardiovascular disease (CVD) was then determined. Further investigations in human cultured cells and in aged LDLR-/- mice prone to development of obesity-associated complications were performed. RESULTS: SAd clusterin correlated with IR, multiple CVD biomarkers, and CVD risk, independent of traditional risk factors. Circulating human clusterin exhibited similar associations. In human adipocytes, palmitate enhanced clusterin secretion, and in human hepatocytes, clusterin attenuated insulin signaling and APOA1 expression and stimulated hepatic gluconeogenesis. LRP2 (megalin), a clusterin receptor, highly expressed in liver, mediated these effects, which were inhibited by LRP2 siRNA. In response to Western diet feeding, an increase in adipocyte clusterin expression was associated with a progressive increase in liver fat, steatohepatitis, and fibrosis in aged LDLR-/- mice. CONCLUSIONS: Adipocyte-derived clusterin is a novel ECM-related protein linking cardiometabolic disease and obesity through its actions in the liver.
引用
- Bradley D, Blaszczak A, Yin Z, et al. Clusterin Impairs Hepatic Insulin Sensitivity and Adipocyte Clusterin Associates With Cardiometabolic Risk. Diabetes Care. 2019. PMID: 30659075. doi:10.2337/dc18-0870
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。